This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 5 CIPO patents and 3 EPO patents. Top assignees: The University of British Columbia, British Columbia Cancer Agency Branch. Active years: 2004-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 959 
1 out of 66 
Years Active: 2004-2025
Title: Christopher J Ong: Innovator in Cancer Therapeutics
Introduction
Christopher J Ong is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of cancer therapeutics, holding a total of seven patents. His work focuses on innovative methods and compositions for treating various types of cancer, showcasing his dedication to advancing medical science.
Latest Patents
One of Ong's latest patents is titled "B1SP fusion protein therapeutics, methods, and uses." This patent provides methods, uses, and pharmaceutical compositions for the treatment of cancer using a B1SP fusion protein. The protein is designed to be administered in a biologically effective amount sufficient to induce cell death in prostate cancer cells or to inhibit their proliferation. The cancers targeted by this invention include prostate cancer, breast cancer, ovarian cancer, bladder cancer, kidney cancer, glioblastoma, and endometrial cancer. Notably, the prostate cancer may be androgen receptor (AR) positive, and the B1SP fusion protein may incorporate a sema domain, a structural stabilization domain, and a half-life extending moiety.
Career Highlights
Christopher J Ong has worked with esteemed institutions such as the University of British Columbia and the British Columbia Cancer Agency Branch. His career reflects a commitment to research and innovation in the medical field, particularly in cancer treatment.
Collaborations
Ong has collaborated with notable professionals in his field, including Martin E Gleave and James William Peacock. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Christopher J Ong is a distinguished inventor whose work in cancer therapeutics has the potential to significantly impact patient care. His innovative approaches and collaborations highlight his commitment to improving treatment options for various cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile